Upgrades:
Kimberly Clark (NYSE:KMB) was upgraded by stock analysts at
Barclays from an “equal weight” rating to an “overweight” rating in a research
report issued to clients and investors on Monday, The Fly reports.
KMB has been the topic of several other reports. Zacks
Investment Research raised Kimberly Clark from a “hold” rating to a “buy”
rating and set a $149.00 target price on the stock in a report on Thursday,
August 22nd. Bank of America reissued a “neutral” rating and set a $143.00
target price (up from $135.00) on shares of Kimberly Clark in a report on
Wednesday, June 19th. ValuEngine lowered Kimberly Clark from a “buy” rating to
a “hold” rating in a report on Thursday, August 1st. Wells Fargo & Co reissued
a “hold” rating and set a $130.00 target price on shares of Kimberly Clark in a
report on Tuesday, July 23rd. Finally, Morgan Stanley increased their target
price on Kimberly Clark from $145.00 to $147.00 and gave the stock an “equal
weight” rating in a report on Wednesday, July 24th. Two analysts have rated the
stock with a sell rating, seven have issued a hold rating and seven have given
a buy rating to the stock. The company currently has an average rating of
“Hold” and an average price target of $131.36. Read more …
Guggenheim upgraded shares of Sanofi (NYSE:SNY) from a
neutral rating to a buy rating in a research note issued to investors on
Monday, BenzingaRatingsTable reports.
Several other equities analysts also recently weighed in on
the company. Jefferies Financial Group reiterated a buy rating on shares of
Sanofi in a research report on Thursday, August 29th. Sanford C. Bernstein
initiated coverage on Sanofi in a research report on Tuesday, September 3rd.
They set an outperform rating and a $52.00 target price on the stock. UBS Group
upgraded Sanofi from a neutral rating to a buy rating in a research report on
Wednesday, August 14th. JPMorgan Chase & Co. restated a neutral rating on
shares of Sanofi in a report on Tuesday, August 6th. Finally, Zacks Investment
Research upgraded Sanofi from a hold rating to a buy rating and set a $47.00
price objective on the stock in a report on Thursday, August 29th. Four
investment analysts have rated the stock with a hold rating and seven have
issued a buy rating to the company’s stock. Sanofi currently has a consensus
rating of Buy and an average target price of $49.67. Read more …
Jefferies Financial Group upgraded shares of Apple
(NASDAQ:AAPL) from a hold rating to a buy rating in a research report report
published on Tuesday morning, The Fly reports. Jefferies Financial Group
currently has $260.00 price objective on the iPhone maker’s stock, up from
their prior price objective of $210.00.
Several other brokerages also recently commented on AAPL.
Longbow Research reiterated a hold rating on shares of Apple in a research note
on Tuesday, September 10th. Raymond James upgraded Apple from a market perform
rating to an outperform rating and set a $250.00 price target on the stock in a
research note on Thursday, July 18th. Goldman Sachs Group dropped their price
target on Apple from $187.00 to $165.00 and set a neutral rating on the stock
in a research note on Friday, September 13th. Monness Crespi & Hardt
restated a buy rating and issued a $265.00 price target (up from $245.00) on
shares of Apple in a research note on Wednesday, July 31st. Finally, Needham
& Company LLC raised their price target on Apple from $225.00 to $250.00
and gave the stock a strong-buy rating in a research note on Wednesday,
September 11th. Four research analysts have rated the stock with a sell rating,
seventeen have given a hold rating, twenty-four have issued a buy rating and
one has issued a strong buy rating to the company. The stock presently has a
consensus rating of Hold and an average price target of $219.47. Read more …
Bank of America upgraded shares of Bank of Nova Scotia
(NYSE:BNS) (TSE:BNS) from a neutral rating to a buy rating in a research note
published on Tuesday, BenzingaRatingsTable reports. The brokerage currently has
$62.00 price target on the bank’s stock, up from their previous price target of
$52.00.
Other equities research analysts have also recently issued
research reports about the stock. Zacks Investment Research cut shares of Bank
of Nova Scotia from a buy rating to a hold rating in a research note on
Thursday, August 29th. ValuEngine cut shares of Bank of Nova Scotia from a hold
rating to a sell rating in a research note on Tuesday, July 2nd. Barclays
reaffirmed an average rating and issued a $78.00 price objective on shares of
Bank of Nova Scotia in a research note on Thursday, May 30th. BMO Capital
Markets cut their price objective on shares of Bank of Nova Scotia from $80.00
to $78.00 and set an outperform rating for the company in a research note on
Wednesday, August 28th. Finally, Canaccord Genuity reaffirmed a hold rating on
shares of Bank of Nova Scotia in a research note on Wednesday, August 28th. One
analyst has rated the stock with a sell rating, seven have given a hold rating
and three have assigned a buy rating to the stock. The company presently has an
average rating of Hold and a consensus target price of $74.14. Read more …